This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Larry Green, PhD
CEO at Ablexis & AlivaMab Discovery Services


Larry is inventor of the AlivaMab® Mouse, CEO and Founder of Ablexis, and Founder and Executive Chairman of AlivaMab Discovery Services. He has over a quarter century of experience in creating and using transgenic mouse platforms for antibody drug discovery and development. Previously at Abgenix (now Amgen), he was an inventor and user of the XenoMouse® technology, which has so far yielded seven approved antibody drugs.

Agenda Sessions

  • Engineering Human Antibodies Discovered with AlivaMab® Mouse into a Bispecific Antibody Therapeutic